0ME:FRA
Twist Bioscience Corp
€158.60
arrow_downward
-0.25%(-0.40) 1D
Sep 29, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0ME...
Open
€153.90
High
€158.60
Low
€153.90
Mkt. cap
12.33B
Avg. vol.
65.00
Volume
0.00
52-wk high
€163.95
52-wk low
€21.69
Shares outstanding
222.04M
No. of employees
979
Open
€153.90
High
€158.60
Low
€153.90
Mkt. cap
12.33B
Avg. vol.
65.00
Volume
0.00
52-wk high
€163.95
52-wk low
€21.69
Shares outstanding
222.04M
No. of employees
979
News stories
From web sources and news partners
TipRanks
·
12 hours ago
Twist Bioscience Pops As Analyst Hikes Price Target
https://www.dars.gov.et/
·
2 months ago
Twist Bioscience Surges on Strong Earnings and AI Drug Discovery Momentum - Financial Health Score
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp